Assessment of Cytotoxicity and Genotoxicity in Patients with Rheumatoid Arthritis and its Relation to Disease Activity and Medications - Egyptian Knowledge Bank - troweb

4478

Assessment of Cytotoxicity and Genotoxicity in Patients with Rheumatoid Arthritis and its Relation to Disease Activity and Medications

Article

Last updated: 22 Jan 2023

Overview Similar Items

Article

Assessment of Chemokine Motif Ligand 4 Gene Polymorphism in Rheumatoid Arthritis Patients and its Correlation with Disease Activity

Article

Biological Therapy and Hematological Parameters in Rheumatoid Arthritis Patients

Article

Evaluation of Drug Effects on IL-17 and TNF levels in Patients with Rheumatoid Arthritis

Article

Assessment of Knowledge Level for Patients with Rheumatoid Arthritis about their Disease

Article

Study of some risk factors for developing rheumatoid arthritis

Article

A Study of the Relation between Human Cytomegalovirus and IL-35 in Rheumatoid Arthritis Disease Patients in Iraq

Article

Clinical and functional outcomes of Rheumatoid Arthritis with analysis of disease characteristics

Article

Evaluation of CCN3 as an Inflammatory Marker of Disease Activity in Rheumatoid Arthritis Patients

Article

The Influence of the MDR1 C3435T Polymorphism on Methotrexate Responsiveness in Rheumatoid Arthritis Patients

Article

Evaluation of Adherence to Drug Treatment in Patients with Rheumatoid Arthritis